You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NDMM

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 4, 2023

Multiple Myeloma Trial in Shanghai (GC012F injection)

Not yet recruiting
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
May 1, 2023

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • 18F-fluciclovine injection
  • 18F-FDG PET/CT
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 31, 2023

Multiple Myeloma Trial (pomalidomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 20, 2022

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

Recruiting
  • Multiple Myeloma
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023

Multiple Myeloma Trial in Shanghai (GC012F injection)

Recruiting
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Aug 1, 2022

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Autologous Stem Cell Transplant Trial in Boston (Isatuximab,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 20, 2021

Multiple Myeloma Trial in Beijing (Ixazomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
    PekingUMCH
Nov 30, 2021

Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

Completed
  • Myeloma Multiple
  • +3 more
  • Afula, Israel
  • +13 more
Jan 26, 2022

Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Alcalá de Henares, Madrid, Spain
  • +67 more
Sep 23, 2022

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Newly Diagnosed Multiple Myeloma Trial in Austria (Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • Isatuximab-Irfc 20 MG/ML [Sarclisa]
  • +2 more
  • Innsbruck, Tirol, Austria
  • +15 more
Aug 24, 2022

Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Changzhou, Jiangsu, China
  • +5 more
Jun 11, 2023

MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

Not yet recruiting
  • Multiple Myeloma
  • Minimal Residual Disease
    • (no location specified)
    Nov 1, 2023

    Multiple Myeloma Trial (Bela, Belamaf, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jan 27, 2023

    Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Graz, Austria
    • +20 more
    Jan 18, 2022

    Patient and Healthcare Provider Satisfaction of Daratumumab Use

    Recruiting
    • Multiple Myeloma
    • +5 more
    • Daratumumab
    • Frankfurt, Hessen, Germany
      Centrum für Hämatologie und Onkologie Bethanien
    Aug 1, 2022

    Myeloma Multiple Trial in Houston (Belantamab mafodotin, Lenalidomide)

    Not yet recruiting
    • Myeloma Multiple
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 29, 2021

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Orange, California
    • +270 more
    Apr 11, 2023

    Plasma Cell Myeloma Trial in Worldwide (Isatuximab SAR650984, Bortezomib, Lenalidomide)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Isatuximab SAR650984
    • +3 more
    • Fort Myers, Florida
    • +103 more
    Nov 3, 2022

    Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Frailty
      • (no location specified)
      Oct 30, 2023

      Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

      Recruiting
      • Multiple Myeloma
      • Scottsdale, Arizona
      • +126 more
      Jan 10, 2023